Habener JF - Search Results

1

GLP-1(32-36)amide, a novel pentapeptide cleavage product of GLP-1, modulates whole body glucose metabolism in dogs.

Elahi D, Angeli FS, Vakilipour A, Carlson OD, Tomas E, Egan JM, Habener JF, Shannon RP. Elahi D, et al. Among authors: habener jf. Peptides. 2014 Sep;59:20-4. doi: 10.1016/j.peptides.2014.06.004. Epub 2014 Jun 14. Peptides. 2014. PMID: 24937653 Free PMC article.

2

Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis.

Tomas E, Habener JF. Tomas E, et al. Among authors: habener jf. Trends Endocrinol Metab. 2010 Feb;21(2):59-67. doi: 10.1016/j.tem.2009.11.007. Epub 2009 Dec 16. Trends Endocrinol Metab. 2010. PMID: 20018525 Free PMC article.

3

GLP-1-derived nonapeptide GLP-1(28-36)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes.

Tomas E, Stanojevic V, Habener JF. Tomas E, et al. Among authors: habener jf. Regul Pept. 2011 Apr 11;167(2-3):177-84. doi: 10.1016/j.regpep.2011.01.003. Epub 2011 Jan 21. Regul Pept. 2011. PMID: 21256872

4

GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.

Tomas E, Wood JA, Stanojevic V, Habener JF. Tomas E, et al. Among authors: habener jf. Regul Pept. 2011 Aug 8;169(1-3):43-8. doi: 10.1016/j.regpep.2011.04.006. Epub 2011 May 4. Regul Pept. 2011. PMID: 21549160

5

Does GLP-1 suppress its own basal secretion?

Elahi D, Ruff DA, Carlson OD, Meneilly GS, Habener JF, Egan JM. Elahi D, et al. Among authors: habener jf. Endocr Res. 2016;41(1):16-20. doi: 10.3109/07435800.2015.1038353. Epub 2015 Jul 17. Endocr Res. 2016. PMID: 26186406 Free PMC article. Clinical Trial.

6

Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.

Egan JM, Meneilly GS, Habener JF, Elahi D. Egan JM, et al. Among authors: habener jf. J Clin Endocrinol Metab. 2002 Aug;87(8):3768-73. doi: 10.1210/jcem.87.8.8743. J Clin Endocrinol Metab. 2002. PMID: 12161508 Clinical Trial.

7

GLP-1 (9-36) amide, cleavage product of GLP-1 (7-36) amide, is a glucoregulatory peptide.

Elahi D, Egan JM, Shannon RP, Meneilly GS, Khatri A, Habener JF, Andersen DK. Elahi D, et al. Among authors: habener jf. Obesity (Silver Spring). 2008 Jul;16(7):1501-9. doi: 10.1038/oby.2008.229. Epub 2008 Apr 17. Obesity (Silver Spring). 2008. PMID: 18421270 Free article.

8

GLP-1 (9-36) amide metabolite suppression of glucose production in isolated mouse hepatocytes.

Tomas E, Stanojevic V, Habener JF. Tomas E, et al. Among authors: habener jf. Horm Metab Res. 2010 Aug;42(9):657-62. doi: 10.1055/s-0030-1253421. Epub 2010 May 28. Horm Metab Res. 2010. PMID: 20645222

9

GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese Mice.

Tomas E, Stanojevic V, McManus K, Khatri A, Everill P, Bachovchin WW, Habener JF. Tomas E, et al. Among authors: habener jf. Diabetes. 2015 Jul;64(7):2409-19. doi: 10.2337/db14-1708. Epub 2015 Apr 9. Diabetes. 2015. PMID: 25858562 Free PMC article.

10

Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes.

Meneilly GS, McIntosh CH, Pederson RA, Habener JF, Ehlers MR, Egan JM, Elahi D. Meneilly GS, et al. Among authors: habener jf. Diabetes Care. 2003 Mar;26(3):837-42. doi: 10.2337/diacare.26.3.837. Diabetes Care. 2003. PMID: 12610046 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters